Previous 10 | Next 10 |
- GATHER2 On-Track to Complete Enrollment in 3Q of this Year - - Conference Call and Webcast Today, May 5, 2021, at 8:00 a.m. ET - IVERIC bio, Inc. (Nasdaq: ISEE) today announced financial and operating results for the quarter ended March 31, 2021 and provided a ...
IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its first quarter 2021 financial and operating results on Wednesday, May 5, 2021. Following the announcement, the Iveric Bio management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to ...
IVERIC bio ([[ISEE]] -2.6%) says its co-founder and Executive Chairman David R. Guyer is stepping down from the board after the company’s 2021 Annual Stockholder Meeting scheduled for May 19, 2021. Dr. Guyer is set to rejoin SV Health Investors as a Venture Partner.Since the ...
IVERIC bio, Inc. (Nasdaq: ISEE) today announced that David R. Guyer, MD, co-founder and Executive Chairman, is stepping down from the Iveric Bio Board after 14 years, effective following Iveric Bio’s 2021 Annual Stockholder Meeting scheduled to be held on May 19, 2021. Dr. Gu...
Gainers: [[PLBY]] +14.5%. [[SLDB]] +9.8%. [[TIGR]] +7.8%. [[IPHI]] +6.4%. [[CLSD]] +5.7%.Losers: [[AAME]] -7.2%. [[HMHC]] -4.9%. [[MRKR]] -4.7%. [[ISEE]] -4.6%. [[NMIH]] -12.5%. For further details see: SLDB, PLBY, AAME and HMHC among after-hours movers
Gainers: [[SNSE]] +17.5%. [[ABCL]] +8.3%. [[AGLE]] +7.6%. [[OLED]] +5.9%. [[EOLS]] +5.4%.Losers: [[CRWD]] -7.0%. [[ARDX]] -6.9%. [[NK]] -6.6%. [[CATB]] -3.2%. [[ISEE]] -3.1%. For further details see: SNSE, AGLE, CRWD and ISEE among after-hours movers
The following slide deck was published by IVERIC bio, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: IVERIC bio, Inc. 2020 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. IVERIC bio, Inc. (NASDAQ: ISEE) Q4 2020 Earnings Call Mar 03, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: IVERIC bio, Inc. (ISEE) Q4 2020 Earnings Call Transcript
IVERIC bio, Inc. (ISEE) Q4 2020 Results Conference Call March 3, 2021 8:00 AM ET Company Participants Kathy Galante - VP of IR & Corporate Communications Glenn Sblendorio - CEO, President & Director Keith Westby - Senior VP & COO David Carroll - Senior VP, CFO & Treasurer Prav...
IVERIC bio (ISEE): Q4 GAAP EPS of -$0.27 misses by $0.01.Cash, cash equivalents and available for sale securities of $210M.FY21 guidance: cash, cash equivalents and available for sale securities will range between $130M-140M.Press Release For further details see: IVERIC bio EPS mis...
News, Short Squeeze, Breakout and More Instantly...
Astellas Completes Acquisition of Iveric Bio PR Newswire TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura , "Astellas") today announced that it has successfully completed the acquisit...
Shares of IVERIC bio, Inc. (NASDAQ: ISEE) traded at a new 52-week high today and are currently trading at $39.73. So far today, approximately 1.78M shares have been exchanged, as compared to an average 30-day volume of 5.04M shares. IVERIC bio, Inc., a biopharmaceutical company, discovers and...
IVERIC bio, Inc. (NASDAQ: ISEE) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 1.93% on the day to $38.77. IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal disease...